![Anna Protopapas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Protopapas
Président chez
NUVALENT, INC.
Fortune : 948 250 $ au 31/05/2026
Profil
Ms. Anna Protopapas is a Chief Executive Officer & Director at Flare Therapeutics, Inc. and an Independent Chairman at Nuvalent, Inc. She is on the Board of Directors at Flare Therapeutics, Inc. Ms. Protopapas was previously employed as an Independent Director by Dicerna Pharmaceuticals, Inc., an Independent Director by ARIAD Pharmaceuticals, Inc., an Executive VP-Global Business Development by Takeda Pharmaceutical Co., Ltd., a Head-Global Business Development by Takeda Pharmaceuticals International, Inc., and a President & Chief Executive Officer by Takeda Oncology Co. She also served on the board at Bioverativ, Inc., Mersana Therapeutics, Inc. and Ensemble Therapeutics Corp.
She received her undergraduate degree from Princeton University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,01 % | 16/06/2026 | 8 590 ( 0,01 % ) | 948 250 $ | 31/05/2026 |
| 06/01/2026 | 0 ( -.--% ) | - $ | 31/12/2025 |
Postes actifs de Anna Protopapas
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | Président | 30/03/2022 |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur Général | 30/06/2026 |
Anciens postes connus de Anna Protopapas
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur Général | 10/09/2023 |
| DICERNA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 03/06/2021 |
| BIOVERATIV INC | Directeur/Membre du Conseil | 08/03/2018 |
| ARIAD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/01/2017 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Corporate Officer/Principal | 01/10/2014 |
Formation de Anna Protopapas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
